RECURRENT OVARIAN CLEAR CELL ADENOCARCINOMA
Clinical trials for RECURRENT OVARIAN CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test powerful new Immune-Boosting cocktail against tough ovarian cancers
Disease control Recruiting nowThis study is testing whether adding a new immune-stimulating drug (CDX-1140) to two existing cancer drugs works better for women whose ovarian cancer has returned. About 80 participants will receive either the standard two-drug combination or the new three-drug combination, give…
Matched conditions: RECURRENT OVARIAN CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test new drug duo to target Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis early-stage study is testing a new combination of two oral drugs, M1774 and ZEN-3694, for women with recurrent ovarian or endometrial cancer. The main goals are to find the safest and most effective dose and to see how well the drugs work together to stop cancer cell growth.…
Matched conditions: RECURRENT OVARIAN CLEAR CELL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC